Biggest Stock Gainers Year to Date on NASDAQ
Today we are looking at companies that have had the greatest percentage increase in share price year to date.
Top 25 Companies
Lists like these are always interesting to look at as they tell more than one story. Companies that are experiencing dramatic increases in share price can do so for a variety of reasons. These can include, the sector they are in has turned (such as companies in the commodities space or a new sector that has huge future potential), the company is in talks to be taken over, or the company has restructured and earnings are turning better than expected.
In this list we have selected the top 25 companies based on their percentage increase in share price year to date.
Today’s Data on NASDAQ
Today’s data is for companies listed on the NASDAQ.
|LPTX||Leap Therapeutics Inc||492.742518||YTD|
|MYOS||Myos Rens Technology Inc||226.271186||YTD|
|OREX||Orexigen Therapeutics Inc||194.252874||YTD|
|SGNL||Signal Genetics Inc||189.421158||YTD|
|NAKD||Naked Brand Group Inc||184.000000||YTD|
|CALA||Calithera Biosciences Inc||172.307692||YTD|
|KBSF||KBS Fashion Group Ltd||158.810818||YTD|
|FWP||Forward Pharma A/S||100.333333||YTD|
|IOTS||Adesto Technologies Corp||100.000000||YTD|
|PME||Pingtan Marine Enterprise Ltd||96.551724||YTD|
|FFHL||Fuwei Films (Holdings) Co Ltd||86.338798||YTD|
|CERU||Cerulean Pharma Inc||83.563965||YTD|
|BNTC||Benitec Biopharma Ltd||80.392157||YTD|
|CLRB||Cellectar Biosciences Inc||74.590164||YTD|
|CGIX||Cancer Genetics Inc||74.074074||YTD|
|GLBS||Globus Maritime Ltd||74.019608||YTD|
|ESPR||Esperion Therapeutics Inc||67.891374||YTD|
|SBLK||Star Bulk Carriers Corp.||66.927593||YTD|
|WINS||Wins Finance Holdings Inc||65.000000||YTD|
|BVXV||BiondVax Pharmaceuticals Ltd||63.310448||YTD|
|ASMB||Assembly Biosciences Inc||62.880658||YTD|
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
Pulmatrix has 22 employees and is headquartered in United States.
Pulmatrix Inc is developing inhaled therapies to address serious pulmonary disease using its clinically validated, proprietary iSPERSE technology.
LPTX:NAS Leap Therapeutics
Leap Therapeutics has 13 employees and is headquartered in United States.
Leap Therapeutics Inc is an immuno oncology company with two clinical stage programs which includes DKN-01 and TRX518.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.